Sara E. Mole

发表

A homogeneous PCR method for rapid detection of the most common mutations in the neuronal ceroid lipofuscinosis genes CLN1 and CLN2.

Paul G. Rothberg, Adam R. Leman, Denia Ramirez-Montealegre, 2005 .

Small animal models of NCL

Jonathan D. Cooper, Sara E. Mole, Claire Russell, 2011 .

The 8th International Congress on Neuronal Ceroid Lipofuscinoses (Batten Disease)

Sara E. Mole, Mark Gardiner, Hannah M. Mitchison, 2001 .

The NCLs: Evolution of the Concept and Classification

Sara E. Mole, Matti Haltia, Milan Elleder, 2011 .

Characterization of neuronal ceroid lipofuscinosis in Argentina

Sara E. Mole, I. Noher de Halac, Inés Adriana Cismondi, 2007 .

Physical and transcript mapping of the CLN6 critcal region on chromosome 15q22-23.

Sara E. Mole, Re Williams, Jd Sharp, 1999 .

Table 4. [Diagnostic Algorithm for NCL Diseases].

Sara E. Mole, Ruth E Williams, 2013 .

Mice with a targeted disruption of the Batten disease gene (CLN3) display a progressive storage disorder

Sara E. Mole, Robert L. Nussbaum, Hannah M. Mitchison, 1998 .

A 30-year follow-up of a patient with mutations in CLN3 and protracted disease course

Sara E. Mole, Taina Autti, Leena Lauronen, 2009 .

CLN4: adult NCL

Sara E. Mole, Hans H. Goebel, J.-J. Martin, 1999 .

Mutations in CLN1, CLN2, CLN3 and CLN5

Sara E. Mole, 1999 .

Animal models of NCL

Sara E. Mole, Brian D. Lake, F Lingaas, 1999 .

The neuronal ceroid-lipofuscinoses: Evolution of the concept and classification

Sara E. Mole, Matti Haltia, Milan Elleder, 2011 .

CLN5 – Finnish variant late infantile NCL

Sara E. Mole, Leena Peltonen, Matti Haltia, 1999 .

IDENTIFICATION OF POTENTIAL BIOMARKERS AND MODIFIERS OF CLN3 DISEASE

Sara E. Mole, AH Lebrun, P Moll-Kosrawi, 2010 .